Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

752.38
-7.9111-1.04%
Number of Gainers:2
Number of Losers:2
Number of Flat:- -
PE:- -
High:772.14
Open:765.27
Low:736.23
Close:760.29
Volume:59.32M
Turnover:1.14B
Market Cap:24.23B
Float Cap:18.51B

Loading ...

Tempus AI EVP, Chief Legal Officer Andrew Polovin Disposes of 2,951 Common Shares for $221,325

Reuters
·
Sep 19

Tempus AI Stock (TEM) Surges 40% in a Week — Is More Upside Ahead?

TIPRANKS
·
Sep 18

Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak

Dow Jones
·
Sep 18

Recursion’s REC-7735 Trial: Early Precision Oncology Data That Could Move RXRX

TIPRANKS
·
Sep 18

Tempus AI rises 14.5%

TIPRANKS
·
Sep 18

Danaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi

TIPRANKS
·
Sep 16

ETF Daily | CRCD Surges 22%; TEMT Jumps 22%; ERX Climbs 4%; XRPT, UXRP, XXRP Sink 23%; Energy ETFs Lead Gains

ETF Tracker
·
Sep 16

Tempus AI Inc Stock (TEM) Moved Up by 7.35% on Sep 15: What Investors Need To Know

TradingKey
·
Sep 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Recursion Pharmaceuticals (RXRX), Teladoc (TDOC) and Oscar Health (OSCR)

TIPRANKS
·
Sep 16

Tempus AI Founder Supports Anthropic CEO’s Call for Slowdown - Bloomberg News

THOMSON REUTERS
·
Sep 15

Tempus AI CEO Sees Healthcare Sector as Biggest AI Beneficiary

Dow Jones
·
Sep 15

Tempus AI to build multimodal whole-genome dataset for AI-driven healthcare

TIPRANKS
·
Sep 11

Tempus AI Launches Effort to Build 100,000 Whole-Genome Dataset Linked to Clinical Outcomes

Reuters
·
Sep 11

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

THOMSON REUTERS
·
Sep 11

Tempus AI, - General Availability of Dataset Planned for Mid-2027

THOMSON REUTERS
·
Sep 11

Recursion Pharma CEO Najat Khan Sells 22,408 Shares for $78,822

Reuters
·
Sep 11

Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics today

TIPRANKS
·
Sep 10

Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology

TIPRANKS
·
Sep 10

Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent

Reuters
·
Sep 10

Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology

THOMSON REUTERS
·
Sep 10